Ar. Farina et al., IDENTIFICATION OF PLASMINOGEN IN MATRIGEL(TM) AND ITS ACTIVATION BY RECONSTITUTION OF THIS BASEMENT-MEMBRANE EXTRACT, BioTechniques, 21(5), 1996, pp. 904-909
Matrigel(TM) a basement membrane (BM) extract of the Engelbreth-Holm-S
warm (EHS) sarcoma, used in tumor invasion assays, was found to contai
n plasminogen. Plasminogen was identified, using Western blot analysis
and casein zymograms, by comparison with human plasminogen. Matrigel
contained approximately 20-100 ng of plasminogen per 100 mu g of prote
in as determined by these assays. Matrigel reconstitution and incubati
on at 37 degrees C caused activation of plasminogen, which was serine
protease dependent and involved tissue plasminogen activator (tPA) as
an anti-tPA antibody which inhibited activation. This reconstitution a
nd incubation also caused leupeptin-inhibitable degradation of Matrige
l components as assessed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis. Degradation of the BM extract copolymerized in zymogr
ams was caused by human plasminogen and plasminogen in the Matrigel. M
aximal plasmin activity following incubation of Matrigel at 37 degrees
C for 16 h, was equivalent to approximately 10 ng of purified plasmin
using the plasmin substrate D-Val-Leu-Lys p-nitroanilide. Matrigel, t
herefore, contained all the components of the plasmin-generating syste
m, including plasminogen. The plasmin generated degraded Matrigel comp
onents and exogenous substrates. Our data suggest that, since this tum
or BM acts as a reservoir for enzymes of the plasmin-generating system
, caution should be taken by investigators interpreting data concernin
g the effects of Matrigel on cell behavior and in particular cellular
invasion.